Evaluation of Alerts in Promoting Bone Densitometry Scans

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to assess, prospectively, the effect of provider-facing alerts for bone densitometry scans with and without a single-click best practice alert (BPA) on scan orders and completions. The investigators hypothesize that the remaining alerts left in place (via health maintenance topics and an actionable item in the electronic health record sidebar) will be as effective without the BPA compared to the alerts with a BPA.

Clinical Trial Description

Standard care for bone densitometry scans at Geisinger--i.e., dual-energy x-ray absorptiometry (DXA) scans--involves (1) an alert under the health maintenance topics tab in Epic, (2) an actionable item in a sidebar (Storyboard), (3) and a single-click best practice alert (BPA). Storyboard and the BPA theoretically serve a redundant function, but it is possible that combined alerting is effective. Therefore, the investigators plan to evaluate whether the BPA for DXA scans will increase the percentage of DXA scans ordered and completed. For this evaluation, the investigators will randomly assign (by odd and even MRN) half of patients who need DXA scans to go through standard care (including the single-click BPA) and half of patients to have no BPA shown to their provider, but only the health maintenance topic and actionable Storyboard alert. This evaluation will help the investigators determine whether redundant, more traditional alerts such as BPAs are helpful or can be removed from alerts for DXA scans. The randomization of patients to different alert conditions will be in place until 4,200 participants have been reached (estimated sample to detect 4% absolute difference, rounded to nearest hundred) or 6 months, whichever comes first. To account for delays in updating clinical databases, the outcome data will pulled 3 months after each encounter (for a maximum study period of 9 months). The main analysis will use a logistic regression to compare the two groups. Exploratory analyses will also examine the time from order to completion to examine any effect on timing between arms. Another set of exploratory analyses will also examine the number of other BPAs firing to see if alert fatigue influenced the number of orders or completions or interacted with the experimental conditions. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04955652
Study type	Interventional
Source	Geisinger Clinic
Contact
Status	Withdrawn
Phase	N/A
Start date	March 2022
Completion date	December 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05203146` - PIMPmyHospital: a Mobile App to Improve Emergency Care Efficiency and Communication	N/A
Completed	`NCT04105751` - Testing a Novel Manual Communication System for Mechanically Ventilated ICU Patients	N/A
Completed	`NCT04595695` - The Effect of Clear Masks in Improving Patient Relationships	N/A
Completed	`NCT05540444` - RadConnect Communication Application
Recruiting	`NCT04317664` - Intervention to Improve Driving Practices Among High-Risk Teen Drivers	Phase 3
Completed	`NCT05812599` - Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers	N/A
Completed	`NCT03221985` - ESM Pilot: Mobile Phones and Psychology	N/A
Completed	`NCT02267265` - Pilot Study of Novel Postpartum Educational Video Intervention	N/A
Completed	`NCT03203018` - Health Literacy and Cardiovascular Knowledge Workshop in Women From Disadvantaged Communities	N/A
Completed	`NCT02619474` - The Effect of Whiteboards on Patient Satisfaction	N/A
Completed	`NCT02695316` - Barrier-free Communication in Maternity Care of Allophone Migrants	N/A
Completed	`NCT01933789` - Improving Communication About Serious Illness	N/A
Completed	`NCT01697137` - Patient and Physician Intervention to Increase Organ Donation	N/A
Completed	`NCT01459744` - An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations	N/A
Recruiting	`NCT01170000` - Timely End-of-Life Communication to Parents of Children With Brain Tumors	N/A
Completed	`NCT01040975` - Teen CHAT: Improving Physician Communication With Adolescents About Healthy Weight	N/A
Completed	`NCT03044145` - The Cultural Formulation Interview-Engagement Aid	N/A
Recruiting	`NCT04533126` - Channels of Communication & Brain Functioning: Pilot fMRI Study
Withdrawn	`NCT03901547` - Emotion Regulation and Burnout Impact on Communication Documentation	N/A
Completed	`NCT06081660` - Advance Care Planning for Older Latinos With Chronic Illness	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.